Our cells follow 24-hour circadian rhythms that regulate our blood sugar levels and are heavily influenced by light exposure.

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2DHIGH POINT, N.C., Dec. 18, 2025 ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may protect against vertebral fractures in people with diabetes, ...

Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview: Insulet Corporation is running a new clinical study titled ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

Research shows that following either the Mediterranean, DASH, or AHEI diet may lower the risk of developing type 2 diabetes.

Texture analysis can identify retinal changes during early stages of type 2 diabetes, according to a study published in Eye ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Sudden cardiac death is much more common in people with type 1 and type 2 diabetes than in the general population, and it ...

A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...